Docosanol
- Generic Name
- Docosanol
- Brand Names
- Abreva
- Drug Type
- Small Molecule
- Chemical Formula
- C22H46O
- CAS Number
- 661-19-8
- Unique Ingredient Identifier
- 9G1OE216XY
- Background
Docosanol is a drug used for topical treatment for recurrent herpes simplex labialis episodes (episodes of cold sores or fever blisters). A saturated 22-carbon aliphatic alcohol, docosanol exhibits antiviral activity against many lipid enveloped viruses including herpes simplex virus (HSV). Docosanol inhibits fusion between the plasma membrane and the herpes...
- Indication
For the topical treatment of recurrent oral-facial herpes simplex episodes (cold sores or fever blisters).
- Associated Conditions
- Cold Sore
- Associated Therapies
- -
Efficacy and Safety of Acyclovir-penciclovir Cream Versus an Abreva in the Suppression of Herpes Simplex Virus Eruptions
- First Posted Date
- 2024-08-19
- Last Posted Date
- 2024-12-10
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 40
- Registration Number
- NCT06558838
- Locations
- 🇺🇸
University of Utah MidValley Dermatology, Murray, Utah, United States
EDTA Eye Drops Compared to Abreva for Herpes Simplex Virus Eruptions
- First Posted Date
- 2021-05-19
- Last Posted Date
- 2024-12-10
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 20
- Registration Number
- NCT04893577
- Locations
- 🇺🇸
University of Utah MidValley Dermatology, Murray, Utah, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath